Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich basic protein 1 (PROB1) is an intracellular protein encoded by the PROB1 gene on human chromosome 5q31.2[1]. It is comprised of 1015 amino acids with two distinct proline-rich regions and a domain of unknown function (DUF)[1]. The secondary structure is predicted to be mainly random coil due to the prevalence of proline residues, with some alpha helices and beta sheets[1]. PROB1 does not contain transmembrane domains and is localized to the nucleoplasm, particularly in cardiac and skeletal muscle tissue, where measurable protein is most abundant[1][7]. While ubiquitous mRNA expression is noted across many tissues, its protein expression appears more tissue-selective[1][3][7].\n\nA variety of post-translational modifications are predicted (e.g., S-palmitoylation, O-GlcNAcylation, phosphorylation)[1]. There are no known functional protein interaction partners, although coexpression with SPATA24 and JADE2 has been observed[1]. Currently, no drugs target PROB1, and its functional and clinical significance remain understudied. However, genetic variants have been linked to keratoconus, as well as altered expression in certain cancers and inflammatory states[1][7]. PROB1 lacks known paralogs in humans but has orthologs across mammals[1].\n\nOverall, PROB1 is a proline-rich, intracellular protein with unclear physiological roles and limited disease association evidence; it is not a validated drug target, nor does it fit into established molecular families such as receptors or enzymes[1][7].
None known; no mechanisms established for drugs targeting this protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich basic protein 1 (PROB1).